# Studies about: coffee and longevity Learning about a field or a topic, rather than looking for one fact? Open its map instead: https://ask.sciencemadereadable.com/map/coffee%20and%20longevity gives the research groups inside it, each with its key papers, rising work, reviews to start with and experts; then read the groups that matter in full (every paper with its abstract), as that page explains. A list like the one below shows only the closest papers, not how the field divides. By meaning: the closest papers in what they are about, even in other words. Best first. Titles and abstracts from OpenAlex, not full texts. Options after `?`, e.g. `?k=30&year_from=2020` (k up to 100; also year_to, type=review, open_access=true, abstracts=false). The same search as JSON: https://api.sciencemadereadable.com/api/data/search?q=coffee%20and%20longevity · guide: https://api.sciencemadereadable.com/api/data/llms.txt ## 1. Association between coffee consumption and life expectancy: a prospective cohort study from NHANES 2001–2018 2025 · Public Health Nutrition · Guangcan Yan; Xiaoqi Dai; Yun Yan; and 3 more · cited 3 times · article · open access Link: https://doi.org/10.1017/s1368980025100888 · on the map of science, with its citations: https://sciencemadereadable.com/?work=10.1017/s1368980025100888 Read in plain words: https://sciencemadereadable.com/?paper=10.1017/s1368980025100888 OBJECTIVE: To assess the association between coffee consumption and life expectancy among the US adults. DESIGN: Prospective cohort. SETTING: National representative survey in the United States, 2001-2018. PARTICIPANTS: A total of 43 114 participants aged 20 years or older with complete coffee consumption data were included from National Health and Nutrition Examination Survey 2001-2018. RESULTS: Over a median follow-up of 8·7 years, 6234 total deaths occurred, encompassing 1929 deaths from CVD and 1411 deaths from cancer. Based on the nationally representative survey, we found that coffee consumption is associated with longer life expectancy. The estimated life expectancy at age 50 was 30·06 years (95 % CI, 29·68, 30·44), 30·82 years (30·12, 31·57), 32·08 years (31·52, 32·70), 31·24 years (30·29, 32·19), and 31·45 years (30·39, 32·60) in participants consuming 0, ≤ 1, 1 to ≤ 2, 2 to ≤ 3, and > 3 cups of coffee per day, respectively. Consequently, compared with non-coffee drinkers, participants who consumed 1 to ≤ 2 cups/day had a gain of 2·02 years (1·17, 2·85) in life expectancy on average, attributable to a 0·61-year (29·72 %) reduction in CVD deaths. Similar benefits were found in both males and females. CONCLUSION: Our findings suggest that moderate coffee consumption (approximately 2 cups per day) could be recommended as a valuable component of a healthy diet and may be an adjustable effective intervention measure to increase life expectancy. ## 2. Coffee for Cardioprotection and Longevity 2018 · Progress in Cardiovascular Diseases · James Henry O’Keefe; James J. DiNicolantonio; Carl J. Lavie · cited 110 times · article Link: https://doi.org/10.1016/j.pcad.2018.02.002 · on the map of science, with its citations: https://sciencemadereadable.com/?work=10.1016/j.pcad.2018.02.002 Coffee, a complex brew containing hundreds of biologically active compounds, exerts potent effects on long-term human health. Recently, a plethora of studies have been published focusing on health outcomes associated with coffee intake. An inverse association between coffee consumption and all-cause mortality has been seen consistently in large prospective studies. Habitual coffee consumption is also associated with lower risks for cardiovascular (CV) death and a variety of adverse CV outcomes, including coronary heart disease (CHD), congestive heart failure (HF), and stroke; coffee's effects on arrhythmias and hypertension are neutral. Coffee consumption is associated with improvements in some CV risk factors, including type 2 diabetes (T2D), depression, and obesity. Chronic coffee consumption also appears to protect against some neurodegenerative diseases, and is associated with improved asthma control, and lower risks for liver disease and cancer. Habitual intake of 3 to 4 cups of coffee appears to be safe and is associated with the most robust beneficial effects. However, most of the studies regarding coffee's health effects are based on observational data, with very few randomized controlled trials. Furthermore, the possible benefits of coffee drinking must be weighed against potential risks, which are generally due to its high caffeine content, including anxiety, insomnia, headaches, tremulousness, and palpitations. Coffee may also increase risk of fracture in women, and when consumed in pregnancy coffee increases risk for low birth weight and preterm labor. ## 3. Impact of coffee intake on human aging: Epidemiology and cellular mechanisms 2024 · Ageing Research Reviews · Cátia R. Lopes; Rodrigo Antunes Cunha · cited 24 times · review · open access Link: https://doi.org/10.1016/j.arr.2024.102581 · on the map of science, with its citations: https://sciencemadereadable.com/?work=10.1016/j.arr.2024.102581 The conception of coffee consumption has undergone a profound modification, evolving from a noxious habit into a safe lifestyle actually preserving human health. The last 20 years also provided strikingly consistent epidemiological evidence showing that the regular consumption of moderate doses of coffee attenuates all-cause mortality, an effect observed in over 50 studies in different geographic regions and different ethnicities. Coffee intake attenuates the major causes of mortality, dampening cardiovascular-, cerebrovascular-, cancer- and respiratory diseases-associated mortality, as well as some of the major causes of functional deterioration in the elderly such as loss of memory, depression and frailty. The amplitude of the benefit seems discrete (17 % reduction) but nonetheless corresponds to an average increase in healthspan of 1.8 years of lifetime. This review explores evidence from studies in humans and human tissues supporting an ability of coffee and of its main components (caffeine and chlorogenic acids) to preserve the main biological mechanisms responsible for the aging process, namely genomic instability, macromolecular damage, metabolic and proteostatic impairments with particularly robust effects on the control of stress adaptation and inflammation and unclear effects on stem cells and regeneration. Further studies are required to detail these mechanistic benefits in aged individuals, which may offer new insights into understanding of the biology of aging and the development of new senostatic strategies. Additionally, the safety of this lifestyle factor in the elderly prompts a renewed attention to recommending the maintenance of coffee consumption throughout life as a healthy lifestyle and to further exploring who gets the greater benefit with what schedules of which particular types and doses of coffee. ## 4. Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population 2007 · British Journal Of Nutrition · Pertti Happonen; Esa Läärä; Liisa A. Hiltunen; and 1 more · cited 55 times · article · open access Link: https://doi.org/10.1017/s0007114507871650 · on the map of science, with its citations: https://sciencemadereadable.com/?work=10.1017/s0007114507871650 The present study assessed the relationship between coffee consumption and mortality in a home-dwelling elderly population. A population-based cohort of 817 men and women born in 1920 or earlier and living in northern Finland provided complete data on daily coffee consumption and other variables at the baseline examination in 1991-1992. Deaths were monitored through to the end of 2005 by national death certificates, resulting in 6960 person-years of follow-up. Hazard rate ratios for mortality by daily coffee intake were estimated by Poisson regression models adjusted for some known predictors of mortality. During 14.5 years of follow-up, 623 deaths occurred. The total mortality rate was inversely related to the number of cups (average volume, 125 ml) of coffee consumed daily. After adjustment for age, sub-period of follow-up, sex, marital status, basic educational level, previous occupational group, current smoking, BMI, history of myocardial infarction, self-rated health and presence of diabetes, cognitive impairment or physical disability, the estimated relative risk reduction of total mortality per an increment of one more cup of coffee per d reported at baseline was 4 (95% CI 0, 8) %. The observed associations between coffee consumption and mortality from CVD, cancer, and other or unknown causes, respectively, were qualitatively similar to that of total mortality but the estimates were less precise. The effect of coffee consumption at baseline appeared to attenuate after 10 years since the start of follow-up. The present study provides evidence for daily (caffeine-containing) coffee intake being inversely associated with mortality in the elderly. ## 5. Habitual coffee consumption and risk of frailty in later life: the Longitudinal Aging Study Amsterdam (LASA) 2025 · European Journal of Nutrition · Mette van der Linden; Hanneke A. H. Wijnhoven; Laura S. Schaap; and 2 more · cited 3 times · article · open access Link: https://doi.org/10.1007/s00394-025-03683-0 · on the map of science, with its citations: https://sciencemadereadable.com/?work=10.1007/s00394-025-03683-0 Read in plain words: https://sciencemadereadable.com/?paper=10.1007/s00394-025-03683-0 This study examined associations of current habitual and midlife coffee consumption with risk of (pre-)frailty in 1161 community-dwelling older adults (≥ 55 years) participating in the Longitudinal Aging Study Amsterdam.Habitual and retrospectively assessed midlife (ages 40-65) coffee consumption was measured using questionnaires and divided into five categories (no coffee, > 0-2, > 2-4, > 4-6, > 6 cups/day). Frailty status was assessed using Fried's five-component frailty phenotype. Generalized estimating equations, Cox proportional hazards models, and logistic regression analyses were performed to assess the associations of coffee consumption with frailty and pre-frailty prevalence, and the 3- and 7-year incidence of (pre)frailty.Habitual coffee consumption of > 4-6 and > 6 cups/day was associated with lower odds of frailty compared with consumption of > 0-2 cups/day (ORs (95%CI) of 0.36 (0.16-0.82) and 0.37 (0.16-0.84), respectively). Similar but statistically non-significant associations were found for coffee consumption during midlife and between habitual coffee consumption and the 3- and 7-year incidence of frailty, except for a statistically significant lower hazard (HR: 0.41 [95%CI 0.23-0.71]) of frailty after 7 years for the consumption of > 2-4 cups/day compared to > 0-2 cups/day. No associations were found between coffee consumption and pre-frailty, with the exception of lower odds for those who consumed > 2-4 cups/day compared to > 0-2 cups/day (OR 0.73 [95%CI 0.54-0.99])The results of this study indicate that higher habitual coffee consumption is associated with lower odds of frailty. Further research is needed to confirm our findings and investigate possible underlying mechanisms by which coffee might influence frailty development. ## 6. Associations of Coffee and Tea Consumption With Survival to Age 90 Years Among Older Women 2020 · Journal of the American Geriatrics Society · Aladdin H. Shadyab; JoAnn E. Manson; Juhua Luo; and 10 more · cited 9 times · article · open access Link: https://doi.org/10.1111/jgs.16467 · on the map of science, with its citations: https://sciencemadereadable.com/?work=10.1111/jgs.16467 BACKGROUND: Coffee and tea are two of the most widely consumed beverages worldwide and have been associated with reduced risk of mortality in some studies. However, it is unknown whether consumption of these beverages is associated with survival to an advanced age. OBJECTIVE: To examine associations of coffee and tea consumption with survival to age 90 years. DESIGN: Prospective cohort study among participants from the Women's Health Initiative, recruited during 1993 to 1998 and followed up until March 31, 2018. SETTING: The setting included 40 US clinical centers. PARTICIPANTS: A racially and ethnically diverse cohort of 27,480 older women, aged 65 to 81 years at baseline. MEASUREMENTS: Women were classified as having either survived to age 90 years or died before this age. Consumption of caffeinated and decaffeinated coffee and caffeinated tea was assessed at baseline and categorized as 0, 1, 2 to 3, or 4 or more cups/day. Associations of coffee and tea consumption with survival to age 90 years were examined using logistic regression models adjusted for sociodemographic characteristics, lifestyle behaviors, dietary quality, and chronic disease history. RESULTS: A total of 14,659 (53.3%) women survived to age 90 years during follow-up. Caffeinated coffee, decaffeinated coffee, or caffeinated tea consumption was not significantly associated with survival to age 90 years after adjusting for confounders. Findings did not significantly vary by smoking, body mass index, or race/ethnicity. CONCLUSION: No amount of coffee or tea consumption was associated with late-age survival among older women. These findings may be reassuring to older women who consume coffee and tea as part of their daily diets but do not support drinking these beverages to achieve longevity. ## 7. The Relationship of Coffee Consumption with Mortality 2008 · Annals of Internal Medicine · Esther López‐García; Rob M. van Dam; Tricia Y. Li; and 2 more · cited 202 times · article · open access Link: https://doi.org/10.7326/0003-4819-148-12-200806170-00003 · on the map of science, with its citations: https://sciencemadereadable.com/?work=10.7326/0003-4819-148-12-200806170-00003 BACKGROUND: Coffee consumption has been linked to various beneficial and detrimental health effects, but data on its relation with mortality are sparse. OBJECTIVE: To assess the association between coffee consumption and mortality from cardiovascular disease (CVD), cancer, and all causes during 18 years of follow-up in men and 24 years of follow-up in women. DESIGN: Sex-specific Cox proportional hazard models were used to investigate the association between coffee consumption and incidence of all-cause and disease-specific mortality in a prospective cohort study. SETTING: Health Professionals Follow-up Study and Nurses' Health Study. PARTICIPANTS: 41,736 men and 86,214 women with no history of CVD or cancer at baseline. MEASUREMENTS: Coffee consumption was assessed first in 1986 for men and in 1980 for women and then every 2 to 4 years through 2004. Investigators documented 6888 deaths (2049 due to CVD and 2491 due to cancer) among men and 11,095 deaths (2368 due to CVD and 5011 due to cancer) among women. RESULTS: After adjustment for age, smoking, and other CVD and cancer risk factors, the relative risks for all-cause mortality in men across categories of coffee consumption (<1 cup per month, 1 cup per month to 4 cups per week, 5 to 7 cups per week, 2 to 3 cups per day, 4 to 5 cups per day, and >or=6 cups per day) were 1.0, 1.07 (95% CI, 0.99 to 1.16), 1.02 (CI, 0.95 to 1.11), 0.97 (CI, 0.89 to 1.05), 0.93 (CI, 0.81 to 1.07), and 0.80 (CI, 0.62 to 1.04), respectively (P for trend = 0.008). For women, the relative risks were 1.0, 0.98 (CI, 0.91 to 1.05), 0.93 (CI, 0.87 to 0.98), 0.82 (CI, 0.77 to 0.87), 0.74 (CI, 0.68 to 0.81), and 0.83 (CI, 0.73 to 0.95), respectively (P for trend < 0.001). This inverse association was mainly due to a moderately reduced risk for CVD mortality and was independent of caffeine intake. By contrast, coffee consumption was not statistically significantly associated with risk for cancer death after adjustment for potential confounders. Decaffeinated coffee consumption was associated with a small reduction in all-cause and CVD mortality. LIMITATION: Coffee consumption was estimated from self-report; thus, some measurement error is inevitable. CONCLUSION: Regular coffee consumption was not associated with an increased mortality rate in either men or women. The possibility of a modest benefit of coffee consumption on all-cause and CVD mortality needs to be further investigated. ## 8. Coffee Extends Yeast Chronological Lifespan through Antioxidant Properties 2020 · International Journal of Molecular Sciences · Jadwiga Czachor; Michał Miłek; Sabina Galiniak; and 3 more · cited 33 times · article · open access Link: https://doi.org/10.3390/ijms21249510 · on the map of science, with its citations: https://sciencemadereadable.com/?work=10.3390/ijms21249510 Read in plain words: https://sciencemadereadable.com/?paper=10.3390/ijms21249510 Aging is a multifactorial process accompanied by loss of cell function. Science has been looking for factors responsible for aging for many years. However, despite identifying a number of possible causes, the definite reason for aging has been elusive so far. One of the factors contributing to aging is oxygen free radicals. In this context, beneficial effects of coffee on various organisms, including humans, were investigated, although the results are far from unequivocal. In our research, we used the budding yeast—something of a workhorse in many studies, including the studies of aging. So far, the impact of coffee on the aging of cells in the budding yeast experimental setup has little known about it. Here, we provide strong evidence that coffee compounds, particularly flavonoids, are responsible for scavenging free radicals and longevity in yeast lacking Sod1, Sod2 and Rad52 proteins. In this paper, we compared Arabica and Robusta coffee types. We present an analysis of the concentration of caffeine and flavonoids measured by the High-Performance Liquid Chromatography method. We show that Robusta has a much greater antioxidant capacity than Arabica. We also conclude that coffee infusions significantly extend the chronological lifespan of the Saccharomyces cerevisiae yeast cells by protecting cells against reactive oxygen species, double DNA-strand break and decrease in metabolic activity. ## 9. COFFEE CONSUMPTION AND CAUSE-SPECIFIC MORTALITY 1992 · Kristian D. Lindsted; Jan W. Kuzma; James L. Anderson · cited 11 times · article Link: https://agris.fao.org/agris-search/search.do?recordID=GB9526920 · on the map of science, with its citations: https://sciencemadereadable.com/?work=W2340260776 The relationship between reported coffee consumption and specific causes of death was examined in 9484 males enrolled in the Adventist Mortality Study in 1960 and followed through 1985. Coffee consumption was divided into three levels: 3 cups per day. Approximately one third of the subjects did not drink coffee. Cause-specific mortality rates were compared using survival analysis including Cox's proportional hazard model, and controlling for potential confounders such as body mass index, heart disease and hypertension at baseline, race, physical activity, marital status, educational level, smoking history, and dietary pattern. Inclusion of interaction terms between coffee consumption and attained age as time-dependent covariates allowed the hazard ratio to vary with age. Univariate analyses showed a statistically significant association (p < 0.05) for coffee consumption and mortality for most endpoints. Multivariate analyses showed a small but statistically significant association between coffee consumption and mortality from ischemic heart disease, other cardiovascular diseases, all cardiovascular diseases, and all causes of death. For the major causes of death, the hazard ratios decreased from about 2.5 at 30 years of age to 1.0 around 95 years of age. These results indicate that abstinence from coffee leads to compression of mortality rather than an increase in lifespan. ## 10. Association of Coffee Consumption With All-Cause and Cardiovascular Disease Mortality 2013 · Mayo Clinic Proceedings · Junxiu Liu; Xuemei Sui; Carl J. Lavie; and 4 more · cited 91 times · article · open access Link: https://doi.org/10.1016/j.mayocp.2013.06.020 · on the map of science, with its citations: https://sciencemadereadable.com/?work=10.1016/j.mayocp.2013.06.020 OBJECTIVE: To evaluate the association between coffee consumption and mortality from all causes and from cardiovascular disease. PATIENTS AND METHODS: Data from the Aerobics Center Longitudinal Study representing 43,727 participants with 699,632 person-years of follow-up were included. Baseline data were collected by an in-person interview on the basis of standardized questionnaires and a medical examination, including fasting blood chemistry analysis, anthropometry, blood pressure, electrocardiography, and a maximal graded exercise test, between February 3, 1971, and December 30, 2002. Cox regression analysis was used to quantify the association between coffee consumption and all-cause and cause-specific mortality. RESULTS: During the 17-year median follow-up, 2512 deaths occurred (804 [32%] due to cardiovascular disease). In multivariate analyses, coffee intake was positively associated with all-cause mortality in men. Men who drank more than 28 cups of coffee per week had higher all-cause mortality (hazard ratio [HR], 1.21; 95% CI, 1.04-1.40). However, after stratification based on age, younger (<55 years old) men and women showed a significant association between high coffee consumption (>28 cups per week) and all-cause mortality after adjusting for potential confounders and fitness level (HR, 1.56; 95% CI, 1.30-1.87 for men; and HR, 2.13; 95% CI, 1.26-3.59 for women). CONCLUSION: In this large cohort, a positive association between coffee consumption and all-cause mortality was observed in men and in men and women younger than 55 years. On the basis of these findings, it seems appropriate to suggest that younger people avoid heavy coffee consumption (ie, averaging >4 cups per day). However, this finding should be assessed in future studies of other populations. More results: ask for up to 100 with `k`, e.g. `?k=30`.